Up-Regulated Hyaluronan Synthase 2 Mediates Epidermal Growth Factor-Induced Cell Migration and Invasion in Human Endometriotic Stromal Cells.

B. Peng,H. Zhan,P. Yong,P. C. Leung,J. Lin,M. A. Bedaiwy

DOI: https://doi.org/10.1016/j.fertnstert.2016.07.797

IF: 6.7

2016-01-01

Fertility and Sterility

Abstract:Endometriosis is characterized by the outgrowth of endometrial cells outside the uterus. Progression of endometriosis is often associated with endometriotic cell migration and invasion. Epidermal growth factor (EGF) and hyaluronan synthases 2 (HAS2) have been reported to regulate cancer cell migration and invasion. The aims of our study were to examine the expression of HAS2 in endometriotic tissues and to investigate the role of HAS2 in EGF-induced endometriotic stromal cell (ESC) migration and invasion. Eutopic and/or ectopic endometrial tissues were collected from women with/without endometriosis. Primary ESCs isolated from ectopic endometrial tissues and immortalized ESCs (CRL-7566) were used in our in-vitro study. The expression of HAS2 in eutopic and ectopic endometrium was examined by immunohistochemistry and Histoscore method. Primary and immortalized ESCs were treated with EGF alone or in combination with EGF receptor inhibitor AG1478, mitogen-activated protein kinase kinase inhibitor U0126, phosphoinositide 3-kinases inhibitor LY294002, or small-interfering RNA against HAS2. The mRNA levels of HAS2 were measured by RT-qPCR. The protein levels of extracellular signal-regulated kinase (ERK)/phospho-ERK, AKT/phospho-AKT, and HAS2 were examined by Western blot analysis. The protein levels of secreted hyaluronan were measured by enzyme-linked immunosorbent assay. Cell migratory and invasive capability was evaluated by transwell migration and invasion assays, respectively. Elevated HAS2 expression levels were detected in glandular epithelial and stromal cells from ectopic endometrium (n=10) compared to eutopic endometrium from women with (n=10) or without (n=10) endometriosis. Treatment with EGF resulted in increased HAS2 mRNA and protein levels and elevated hyaluronan secretion in ESCs. Additionally, EGF increased ERK and AKT phosphorylation, and pretreatment of U0126 and LY294002 attenuated EGF-induced HAS2 expression. Moreover, EGF treatment significantly increased cell migration and invasion of ESCs, and knockdown of HAS2 attenuated basal and EGF-induced ESC cell migration and invasion. HAS2 expression is elevated in ectopic endometrium from women with endometriosis. EGF induces HAS2 expression in ESCs, which may result in increased cell migration and invasion in these cells.